Description of Collaborative Activity: |
The purpose of this IAA is to utilize a structure approach to evaluate the safety of this frequently used stimulant in a developing animal model in accordance with FDA protocol E0728701. The information from these experiences will enhance our ability to conduct a safety assessment of methylphenidate in humans. |